Neogen Chemicals Ltd
NSE:NEOGEN

Watchlist Manager
Neogen Chemicals Ltd Logo
Neogen Chemicals Ltd
NSE:NEOGEN
Watchlist
Price: 2 069.8 INR 0.26% Market Closed
Market Cap: ₹56.7B

Wall St Price Targets

NEOGEN Price Targets Summary
Neogen Chemicals Ltd

Wall Street analysts forecast NEOGEN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEOGEN is 1 900.84 INR with a low forecast of 1 469.55 INR and a high forecast of 2 618.7 INR.

Lowest Forecast
Price Target
1 469.55 INR
29% Downside
Average Forecast
Price Target
1 900.84 INR
8% Downside
Highest Forecast
Price Target
2 618.7 INR
27% Upside
Neogen Chemicals Ltd Competitors:
Price Targets
FLR
Fluor Corp
4% Upside

Revenue
Forecast

24% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
24% / Year
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 10 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 4 years is 37%.

Gross Profit
Forecast

29% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss
29% / Year
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Over the last 10 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 4 years is 46%.

Operating Income
Forecast

25% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
25% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 10 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 4 years is 36%.

Pre-Tax Income
Forecast

20% / Year
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
20% / Year
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 48%.

Net Income
Forecast

21% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
21% / Year
Past Growth
44% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 10 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 4 years is 44%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NEOGEN's stock price target?
Price Target
1 900.84 INR

According to Wall Street analysts, the average 1-year price target for NEOGEN is 1 900.84 INR with a low forecast of 1 469.55 INR and a high forecast of 2 618.7 INR.

What is the Revenue forecast for Neogen Chemicals Ltd?
Projected CAGR
37%

Over the last 10 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 4 years is 37%.

What is the Gross Profit forecast for Neogen Chemicals Ltd?
Projected CAGR
46%

Over the last 10 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 4 years is 46%.

What is the Operating Income forecast for Neogen Chemicals Ltd?
Projected CAGR
36%

Over the last 10 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 4 years is 36%.

What is the Pre-Tax Income forecast for Neogen Chemicals Ltd?
Projected CAGR
48%

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 48%.

What is the Net Income forecast for Neogen Chemicals Ltd?
Projected CAGR
44%

Over the last 10 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 4 years is 44%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett